A
Accelerate Labs
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Ipamorelin | A | 3 | 8.6 | 7.0 | 9.6 | 16 May 2025 |
| GHK-Cu | A | 2 | 7.2 | 7.2 | 7.2 | 10 Jul 2025 |
| Semaglutide | A | 3 | 7.3 | 7.1 | 7.6 | 16 May 2025 |
| Retatrutide | C | 3 | 5.8 | 4.1 | 6.9 | 16 May 2025 |
| CJC-1295 | D | 4 | 6.8 | 3.6 | 10.0 | 16 May 2025 |
| BPC-157 | D | 3 | 5.1 | 3.9 | 5.9 | 16 May 2025 |
| Melanotan II | E | 2 | 2.0 | 2.0 | 2.0 | 16 May 2025 |
| ACE-031 | X | 1 | 5.2 | 5.2 | 5.2 | 21 May 2025 |
| Adipotide | A | 2 | 5.8 | 4.3 | 7.4 | 26 Jan 2026 |
| AHK-CU | A | 2 | 4.6 | 4.5 | 4.7 | 24 May 2026 |
| AICAR | A | 2 | 6.1 | 5.7 | 6.4 | 21 May 2026 |
| Botulinum toxin | X | 1 | 7.2 | 7.2 | 7.2 | 3 Jun 2025 |
| Cardiogen | A | 2 | 6.5 | 5.6 | 7.5 | 20 May 2026 |
| Cerebrolysin | X | 1 | 6.6 | 6.6 | 6.6 | 27 Feb 2025 |
| CJC-1295 With DAC | A | 2 | 6.2 | 5.4 | 6.9 | 26 Jan 2026 |
| Epithalon | A | 2 | 7.5 | 6.4 | 8.5 | 24 May 2026 |
| HMG | X | 1 | 5.1 | 5.1 | 5.1 | 24 Apr 2025 |
| Hyaluronic acid | A | 2 | 5.4 | 4.0 | 6.8 | 20 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | A | 2 | 8.0 | 6.1 | 9.9 | 20 May 2026 |
| KPV | A | 2 | 6.9 | 6.8 | 7.0 | 21 May 2026 |
| Letrozole | X | 1 | 6.3 | 6.3 | 6.3 | 9 Jun 2025 |
| Liraglutide | X | 1 | 5.4 | 5.4 | 5.4 | 17 Dec 2024 |
| Methylstenbolone | A | 2 | 7.7 | 6.6 | 8.8 | 25 May 2026 |
| Ostarine (MK-2866) | X | 1 | 7.0 | 7.0 | 7.0 | 2 Jul 2025 |
| P21 | X | 1 | 4.6 | 4.6 | 4.6 | 25 Apr 2025 |
| PE 22-28 | A | 2 | 9.2 | 8.7 | 9.7 | 21 May 2026 |
| Phenylacetic acid CAS 103-82-2 | X | 1 | 6.9 | 6.9 | 6.9 | 8 Jul 2025 |
| PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | A | 2 | 5.0 | 5.0 | 5.0 | 21 May 2026 |
| Retatrutide 30mg Pen Kit | A | 2 | 5.0 | 3.5 | 6.6 | 25 May 2026 |
| Salbutamol | X | 1 | 6.6 | 6.6 | 6.6 | 24 Apr 2025 |
| Selank 10mg + Semax 10mg Blend | A | 2 | 6.2 | 5.8 | 6.7 | 19 Jan 2026 |
| Semaglutide Oral | X | 1 | 4.6 | 4.6 | 4.6 | 17 Dec 2024 |
| Superdrol | X | 1 | 7.7 | 7.7 | 7.7 | 21 May 2025 |
| T4 (Levothyroxine) | A | 2 | 5.4 | 5.2 | 5.6 | 19 Jan 2026 |
| Test Suspension | X | 1 | 8.2 | 8.2 | 8.2 | 13 Jun 2025 |
| Tren Hex | X | 1 | 5.5 | 5.5 | 5.5 | 27 Feb 2025 |
| Trestolone Acetate (MENT) Raw | X | 1 | 7.7 | 7.7 | 7.7 | 14 Jan 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 24 May 2026 | Ostarine (MK-2866) | 6.7 | 25mg | 26.5mg | +5.9% | 96.65% | Lab G |
| 24 May 2026 | ACE-031 | 4.0 | 50mg | 57.7mg | +15.5% | 97.88% | Lab F |
| 24 May 2026 | Hyaluronic acid | 4.5 | 30mg | 32.7mg | +8.8% | 98.19% | Lab E |
| 24 May 2026 | Retatrutide 30mg Pen Kit | 4.2 | 50mg | 60.0mg | +20.1% | 95.46% | Lab B |
| 24 May 2026 | Selank 10mg + Semax 10mg Blend | 6.9 | 20mg | 19.5mg | -2.3% | 96.18% | Lab E |
| 24 May 2026 | Semaglutide Oral | 4.0 | 25mg | 22.8mg | -8.8% | 95.87% | Lab B |
| 24 May 2026 | AHK-CU | 5.2 | 5mg | 5.5mg | +9.0% | 98.36% | Lab C |
| 24 May 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 4.9 | 100g | 87.9g | -12.1% | 95.05% | Lab A |
| 23 May 2026 | Phenylacetic acid CAS 103-82-2 | 8.5 | 1g | 1.2g | +23.7% | 95.43% | Lab B |
| 23 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 9.0 | 5mg | 5.4mg | +7.8% | 99.95% | Lab D |
| 21 May 2026 | Cerebrolysin | 6.4 | 30mg | 35.2mg | +17.4% | 97.00% | Lab B |
| 21 May 2026 | CJC-1295 With DAC | 7.5 | 5mg | 4.9mg | -1.6% | 96.59% | Lab B |
| 20 May 2026 | HMG | 6.1 | 5mg | 4.8mg | -4.0% | 99.15% | Lab B |
| 20 May 2026 | PE 22-28 | 9.3 | 5mg | 4.3mg | -14.5% | 97.35% | Lab F |
| 19 May 2026 | Superdrol | 7.1 | 10mg | 10.9mg | +8.8% | 97.71% | Lab E |
| 17 May 2026 | P21 | 5.3 | 20mg | 18.1mg | -9.4% | 97.02% | Lab E |
| 17 May 2026 | Salbutamol | 5.5 | 100mg | 86.4mg | -13.6% | 97.82% | Lab A |
| 17 May 2026 | Selank 10mg + Semax 10mg Blend | 5.5 | 20mg | 23.1mg | +15.6% | 99.25% | Lab A |
| 29 Jan 2026 | KPV | 7.2 | 20mg | 24.8mg | +23.8% | 97.49% | Lab F |
| 29 Jan 2026 | Retatrutide 30mg Pen Kit | 6.0 | 50mg | 62.0mg | +23.9% | 98.19% | Lab B |
| 26 Jan 2026 | Cardiogen | 9.7 | 20mg | 24.3mg | +21.6% | 95.92% | Lab A |
| 26 Jan 2026 | Epithalon | 7.3 | 50mg | 51.3mg | +2.5% | 95.64% | Lab F |
| 26 Jan 2026 | Letrozole | 6.5 | 20mg | 23.0mg | +14.9% | 99.98% | Lab D |
| 19 Jan 2026 | Methylstenbolone | 7.2 | 20mg | 18.9mg | -5.3% | 97.78% | Lab D |
| 9 Jan 2026 | AHK-CU | 4.8 | 50mg | 59.7mg | +19.5% | 95.53% | Lab D |
| 7 Jan 2026 | Tren Hex | 5.3 | 100mg/ml | 101.8mg/ml | +1.8% | 97.68% | Lab A |
| 6 Jan 2026 | CJC-1295 With DAC | 4.0 | 10mg | 10.7mg | +6.9% | 99.56% | Lab B |
| 6 Jan 2026 | KPV | 7.0 | 10mg | 9.7mg | -3.2% | 97.02% | Lab A |
| 29 Dec 2025 | Adipotide | 6.4 | 15mg | 16.4mg | +9.7% | 99.86% | Lab A |
| 12 Dec 2025 | Test Suspension | 6.2 | 100mg/ml | 115.0mg/ml | +15.0% | 98.34% | Lab F |
| 5 Dec 2025 | AICAR | 6.9 | 20mg | 17.6mg | -11.9% | 97.28% | Lab D |
| 5 Dec 2025 | AICAR | 5.6 | 30mg | 29.6mg | -1.5% | 99.58% | Lab G |
| 5 Dec 2025 | Liraglutide | 5.8 | 30mg | 25.6mg | -14.8% | 96.94% | Lab B |
| 17 Nov 2025 | Adipotide | 5.9 | 30mg | 32.3mg | +7.6% | 96.48% | Lab C |
| 14 Nov 2025 | Epithalon | 6.1 | 15mg | 15.8mg | +5.6% | 97.74% | Lab A |
| 14 Nov 2025 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 4.1 | 1g | 1.2g | +20.7% | 96.68% | Lab F |
| 14 Nov 2025 | Trestolone Acetate (MENT) Raw | 9.6 | 10g | 10.4g | +4.3% | 99.44% | Lab F |
| 5 Nov 2025 | Botulinum toxin | 9.1 | 30mg | 29.7mg | -1.1% | 98.59% | Lab E |
| 5 Nov 2025 | T4 (Levothyroxine) | 6.3 | 100mg | 96.5mg | -3.5% | 96.07% | Lab D |
| 4 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 8.7 | 5mg | 5.6mg | +12.5% | 95.00% | Lab E |
| 17 Oct 2025 | Hyaluronic acid | 5.7 | 30mg | 33.2mg | +10.7% | 96.32% | Lab D |
| 17 Oct 2025 | Methylstenbolone | 9.4 | 10mg | 9.0mg | -10.5% | 99.44% | Lab C |
| 9 Oct 2025 | Cardiogen | 7.9 | 10mg | 8.7mg | -13.3% | 96.65% | Lab E |
| 9 Oct 2025 | PE 22-28 | 9.6 | 2mg | 2.0mg | +2.3% | 98.81% | Lab F |
| 3 Oct 2025 | T4 (Levothyroxine) | 6.3 | 25mg | 28.5mg | +13.9% | 96.08% | Lab G |
| 6 Sep 2025 | Ipamorelin | 7.0 | 5mg | (no batch claim) | 4.2mg | -16.0% | White Label / Silver Crimp / Blue Cap |
| 25 Jul 2025 | BPC-157 | 3.9 | 5mg | (no batch claim) | 6.4mg | +28.0% | White Label /Silver Crimp / Purple Cap |
| 23 Jul 2025 | Retatrutide | 4.1 | 10mg | 11.0mgwebsite | 9.2mg | -16.4% | White Label /Silver Crimp / Dark Blue Cap |
| 22 Jul 2025 | Semaglutide | 7.6 | 5mg | 5.2mgwebsite | 4.7mg | -9.4% | White Label / Silver Crimp / Blue Cap |
| 10 Jul 2025 | GHK-Cu | 7.2 | 50mg | (no batch claim) | 59.4mg | +18.8% | White Label /Silver Crimp / Red Cap |
| 10 Jul 2025 | GHK-Cu | 7.2 | 50mg | (no batch claim) | 59.2mg | +18.4% | White Label /Silver Crimp / Red Cap |
| 16 May 2025 | Melanotan II | 2.0 | 10mg | ⚠️ Sample does not contain Melanotan II ? | 06-26-2024 | White Label /Silver Crimp / Yellow Cap |